We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RGLD:NASDAQRoyal Gold, Inc. Analysis

Data as of 2026-09-01 - not real-time

$261.47

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Royal Gold, Inc. is neutral at $261.47, with no clear ordering between short and long averages. It has gained 39.6% over the past 30 days. Momentum indicators put RSI at 69.0 (approaching overbought) with MACD reading bullish. Watch $203.64 as support and $271.43 as the nearer resistance level.
On valuation the read is fair — an earnings multiple of 28.9, absent a reliable peer benchmark. Consensus targets land 15.8% above where the shares trade now. Revenue is growing at 115.5% on a 48.1% profit margin. The 0.72% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 39.4%, a beta of 1.30 and a maximum drawdown of 38.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 4 out of 10.

Top Market Events

Royal Gold, Inc. reported past second-quarter 2026 earnings with sales rising to US$450.54 million and net income to...Royal Gold NASDAQ:RGLD posted second-quarter 2026 results on August 6, and the numbers show a company operating at a...DENVER AP — DENVER AP — Royal Gold Inc.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Trading above the 200-day average of 235.15
  • MACD momentum is positive
  • 30-day price change of +39.6%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 235.15
  • Analyst targets imply +15.8% versus the current price
  • MACD momentum is positive

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Analyst targets imply +15.8% versus the current price
  • Profit margin of 48.1% is healthy
  • Revenue growth of +115.5%

Key Metrics & Analysis

Financial Health

Revenue Growth115.50%
Profit Margin48.05%
P/E Ratio28.9
ROE13.60%
ROA9.35%
Debt/Equity5.19
P/B Ratio2.9
Op. Cash Flow$1.0B
Free Cash Flow$-189505504

Technical Analysis

TrendNeutral
RSI69.0
Support$203.64
Resistance$271.43
MA 20$242.19
MA 50$216.21
MA 200$235.15
MACDBullish
VolumeStable
Fear & Greed Index93.11

Valuation

Fair Value$297.01
Target Price$302.67
Upside/Downside15.76%
GradeFair
TypeGrowth
Dividend Yield0.72%

Risk Assessment

Beta1.30
Volatility39.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.